// IP Marketing video - START// IP Marketing video - END

Drugs giant Novartis posts $2.08 billion Q4 net profit

Drugs giant Novartis posts $2.08 billion Q4 net profit

PanARMENIAN.Net - Swiss drug maker Novartis AG has reported a fourth-quarter net profit of $2.08 billion, AP said.

The result is 72 percent higher than the $1.21 billion net profit reported for the last quarter of 2011 when the Basel-based company took a $900-million after ending its clinical study into wider uses of the hypertension drug Tekturna.

Novartis said Wednesday, January 23 that fourth-quarter sales in 2012 were almost flat at $14.83 billion compared with $14.78 billion in the same period the previous year.

The company also said that long-time chairman and former chief executive Daniel Vasella will leave the board at the next shareholders' meeting at the end of February.

 Top stories
The official said that the EU countries have already issued a mandate for negotiating a corresponding document.
Iran plans to increase natural gas exports to Armenia from 1 million cubic meters per day to 3 million cubic meters in the next few years.
“The two sides are currently preparing the required infrastructure for boosting natural gas exchange,” NIGEC chief Alireza Kameli said.
Sargsyan said fingerprints of some 1.5 million potential voters will have to be collected which requires a lot of work.
Partner news